What happened
NKGen Biotech Korea updated the terms of a private placement (third-party allotment) to raise US$650K, about 0.4% of its market value.
For context, this raise equals about 0.4% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Private placement |
|---|---|
| Raise amount | US$650K |
| vs. market value | 0.4% |
| Filed | 2026-02-19, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260219002419 → open original filing |
Versions of this filing
- 2026-01-15Original
- 2026-02-19Amendment 1 (this page)
Source: DART. Information only, not investment advice.